Navigation Links
California Healthcare Institute Announces Executive Promotion
Date:4/22/2013

LA JOLLA, Calif. (PRWEB) April 22, 2013

The California Healthcare Institute (CHI) announced today the promotion of Holly Frisque, SPHR, to vice president of administration. Frisque, who has been with CHI since 2009, previously served as senior director of operations. CHI is a non-profit public policy research and advocacy organization for California’s biomedical R&D industry.

As vice president of administration, Frisque leads CHI in supervision of the human resources, communications, marketing, finance, membership services, corporate compliance and technology departments.

“For over four years, Holly’s leadership has contributed immensely to the positive direction and growth of CHI. This hard-earned promotion reflects CHI’s commitment to providing the highest level of member service and organizational management,” said CHI President and CEO David L. Gollaher, Ph.D. “Her diligence and professionalism will continue to make CHI a team-oriented and effective biomedical advocacy organization on behalf of our members.”

Frisque joined CHI as office manager of the La Jolla headquarters before being promoted to senior director of operations in 2012. Before joining CHI, Frisque served as the director of administration at Gizmo5 Technologies, Inc. and Linspire, Inc., two software development companies in San Diego. She also led administration for the biotech investment division of Enterprise Partners Venture Capital. Frisque has achieved the Senior Professional in Human Resources designation, reflecting her expertise in strategic management and highlighting her commitment to best practices. Frisque holds a bachelor's degree in psychology and a minor in creative writing from University of California, Riverside.

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10654043.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
2. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
3. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
4. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
5. California Healthcare Institute Appoints Vice President-State Government Affairs
6. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
7. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
8. JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte
9. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
10. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
11. Precision Coating to Showcase Next Generation Coating Deposition Technology at MD&M West Show in Anaheim, California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... host a Key Opinion Leader event to highlight new ... and poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology ... event will be held in-person and via live webcast ... 9:00 AM PST at the Lotte New York Palace ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
Breaking Biology News(10 mins):